Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 2 Study of Nivolumab and Brentuximab Vedotin Consolidation After Autologous Stem Cell Transplantation in Patients with High-Risk Classical Hodgkin Lymphoma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.